Market Segmentation
- Smart Insulin Pens & Pumps Type Outlook (Revenue, USD Million, 2018 - 2030)
- Smart Insulin Pens
- Companion Medical (InPen)
- Novo Nordisk (NovoPen 6 & NovoPen Echo)
- Emperra Gmbh (ESYSTA Pen)
- pendiq intelligent diabetes care (pendiq 2.0)
- Others
- Smart Insulin Pumps
- MiniMed (630G and 670G)
- Accu-Chek (Combo and Insight)
- Tandem (t:slim X2, t:slim G4)
- Insulet (Omnipod)
- myLife Omnipod
- Others
- Smart Insulin Pens
- Smart Insulin Pens & Pumps End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals and Clinics
- Homecare
- Others
- Smart Insulin Pens & Pumps Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- India
- China
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
